OBJECTIVE: To determine the relationship between hyperglycemia and outcome in infants and children after severe traumatic brain injury. DESIGN: Retrospective review of a prospectively collected Pediatric Neurotrauma Registry. SETTING AND PATIENTS: Children admitted after severe traumatic brain injury (postresuscitation Glasgow Coma Scale ≤ 8) were studied (1999-2004). A subset of children (n = 28) were concurrently enrolled in a randomized, controlled clinical trial of early hypothermia for neuroprotection. INTERVENTIONS:Demographic data, serum glucose concentrations, and outcome assessments were collected. METHODS AND MAIN RESULTS:Children (n = 57) were treated with a standard traumatic brain injury protocol. Exogenous glucose was withheld for 48 hrs after injury unless hypoglycemia was observed (blood glucose <70 mg/dL). Early (first 48 hrs) and Late (49-168 hrs) time periods were defined and mean blood glucose concentrations were calculated. Additionally, children were categorized based on peak blood glucose concentrations during each time period (normal, blood glucose <150 mg/dL; mild hyperglycemia, blood glucose ≤ 200 mg/dL; severe hyperglycemia, blood glucose >200 mg/dL). In the Late period, an association between elevated mean serum glucose concentration and outcome was observed (133.5 ± 5.6 mg/dL in the unfavorable group vs. 115.4 ± 4.1 mg/dL in favorable group, p = .02). This association continued to be significant after correcting for injury severity, age, and exposure to insulin (p = .03). Similarly, in the Late period, children within the severe hyperglycemia group had decreased incidence of good outcome compared to children within the other glycemic groups (% good outcome: normal, 61.9%; mild hyperglycemia, 73.7%; severe hyperglycemia, 33.3%; p = .05). However, when adjusted for exposure to insulin, this relationship was no longer statistically significant. CONCLUSIONS: In children with severe traumatic brain injury, hyperglycemia beyond the initial 48 hrs is associated with poor outcome. This relationship was observed in both our analysis of mean blood glucose concentrations as well as among the patients with episodic severe hyperglycemia. This observation suggests a relationship between hyperglycemia and outcome from traumatic brain injury. However, only a prospective study can answer the important question of whether manipulating serum glucose concentration can improve outcome after traumatic brain injury in children.
RCT Entities:
OBJECTIVE: To determine the relationship between hyperglycemia and outcome in infants and children after severe traumatic brain injury. DESIGN: Retrospective review of a prospectively collected Pediatric Neurotrauma Registry. SETTING AND PATIENTS: Children admitted after severe traumatic brain injury (postresuscitation Glasgow Coma Scale ≤ 8) were studied (1999-2004). A subset of children (n = 28) were concurrently enrolled in a randomized, controlled clinical trial of early hypothermia for neuroprotection. INTERVENTIONS: Demographic data, serum glucose concentrations, and outcome assessments were collected. METHODS AND MAIN RESULTS:Children (n = 57) were treated with a standard traumatic brain injury protocol. Exogenous glucose was withheld for 48 hrs after injury unless hypoglycemia was observed (blood glucose <70 mg/dL). Early (first 48 hrs) and Late (49-168 hrs) time periods were defined and mean blood glucose concentrations were calculated. Additionally, children were categorized based on peak blood glucose concentrations during each time period (normal, blood glucose <150 mg/dL; mild hyperglycemia, blood glucose ≤ 200 mg/dL; severe hyperglycemia, blood glucose >200 mg/dL). In the Late period, an association between elevated mean serum glucose concentration and outcome was observed (133.5 ± 5.6 mg/dL in the unfavorable group vs. 115.4 ± 4.1 mg/dL in favorable group, p = .02). This association continued to be significant after correcting for injury severity, age, and exposure to insulin (p = .03). Similarly, in the Late period, children within the severe hyperglycemia group had decreased incidence of good outcome compared to children within the other glycemic groups (% good outcome: normal, 61.9%; mild hyperglycemia, 73.7%; severe hyperglycemia, 33.3%; p = .05). However, when adjusted for exposure to insulin, this relationship was no longer statistically significant. CONCLUSIONS: In children with severe traumatic brain injury, hyperglycemia beyond the initial 48 hrs is associated with poor outcome. This relationship was observed in both our analysis of mean blood glucose concentrations as well as among the patients with episodic severe hyperglycemia. This observation suggests a relationship between hyperglycemia and outcome from traumatic brain injury. However, only a prospective study can answer the important question of whether manipulating serum glucose concentration can improve outcome after traumatic brain injury in children.
Authors: Andrew R Yates; Peter C Dyke; Roozbeh Taeed; Timothy M Hoffman; John Hayes; Timothy F Feltes; Clifford L Cua Journal: Pediatr Crit Care Med Date: 2006-07 Impact factor: 3.624
Authors: Ali Salim; Pantelis Hadjizacharia; Joseph Dubose; Carlos Brown; Kenji Inaba; Linda S Chan; Daniel Margulies Journal: Am Surg Date: 2009-01 Impact factor: 0.688
Authors: Margarita Ramos; Zain Khalpey; Stuart Lipsitz; Jill Steinberg; Maria Theresa Panizales; Michael Zinner; Selwyn O Rogers Journal: Ann Surg Date: 2008-10 Impact factor: 12.969
Authors: Kalia Patricia Ulate; Germano Correia Lima Falcao; Mark Richard Bielefeld; John Mark Morales; Alexandre Tellechea Rotta Journal: Pediatrics Date: 2008-09-08 Impact factor: 7.124
Authors: Anthony A Figaji; A Graham Fieggen; Ncedile Mankahla; Nico Enslin; Ursula K Rohlwink Journal: Childs Nerv Syst Date: 2017-08-14 Impact factor: 1.475
Authors: Haifa Mtaweh; Rebecca Smith; Patrick M Kochanek; Stephen R Wisniewski; Anthony Fabio; Monica S Vavilala; P David Adelson; Nicole A Toney; Michael J Bell Journal: Pediatr Crit Care Med Date: 2014-03 Impact factor: 3.624
Authors: Nigel H Greig; David Tweedie; Lital Rachmany; Yazhou Li; Vardit Rubovitch; Shaul Schreiber; Yung-Hsiao Chiang; Barry J Hoffer; Jonathan Miller; Debomoy K Lahiri; Kumar Sambamurti; Robert E Becker; Chaim G Pick Journal: Alzheimers Dement Date: 2014-02 Impact factor: 21.566
Authors: Michael J Bell; P David Adelson; James S Hutchison; Patrick M Kochanek; Robert C Tasker; Monica S Vavilala; Sue R Beers; Anthony Fabio; Sheryl F Kelsey; Stephen R Wisniewski Journal: Pediatr Crit Care Med Date: 2013-10 Impact factor: 3.624